Article

HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Cancer Cell (Impact Factor: 23.89). 10/2007; 12(3):230-8. DOI: 10.1016/j.ccr.2007.08.004
Source: PubMed

ABSTRACT The antitumorigenic activity of antioxidants has been presumed to arise from their ability to squelch DNA damage and genomic instability mediated by reactive oxygen species (ROS). Here, we report that antioxidants inhibited three tumorigenic models in vivo. Inhibition of a MYC-dependent human B lymphoma model was unassociated with genomic instability but was linked to diminished hypoxia-inducible factor (HIF)-1 levels in a prolyl hydroxylase 2 and von Hippel-Lindau protein-dependent manner. Ectopic expression of an oxygen-independent, stabilized HIF-1 mutant rescued lymphoma xenografts from inhibition by two antioxidants: N-acetylcysteine and vitamin C. These findings challenge the paradigm that antioxidants diminish tumorigenesis primarily through decreasing DNA damage and mutations and provide significant support for a key antitumorigenic effect of diminishing HIF levels.

Download full-text

Full-text

Available from: Dean Felsher, Jul 28, 2015
0 Followers
 · 
142 Views
  • Source
    • "Many anticancer therapies rely on ROS-induced apoptosis. Although generic antioxidant effects on tumor growth are still debated (Gao et al., 2007; Sayin et al., 2014), mitoTEMPO compared to less selective antioxidants preserves physiological ROS signaling (as shown in nonmalignant fibroblasts; Nazarewicz et al., 2013a) and could therefore selectively target tumor cells with abnormal mitochondrial activities. Although we did not find significant primary tumor growth inhibition using mitoTEMPO at 0.7 mg/kg/day (Figure S5E), others (Nazarewicz et al., 2013a) have shown that the therapeutic effects of this drug at higher dose may retard primary tumor growth. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Metastatic progression of cancer is associated with poor outcome, and here we examine metabolic changes underlying this process. Although aerobic glycolysis is known to promote metastasis, we have now identified a different switch primarily affecting mitochondria. The switch involves overload of the electron transport chain (ETC) with preserved mitochondrial functions but increased mitochondrial superoxide production. It provides a metastatic advantage phenocopied by partial ETC inhibition, another situation associated with enhanced superoxide production. Both cases involved protein tyrosine kinases Src and Pyk2 as downstream effectors. Thus, two different events, ETC overload and partial ETC inhibition, promote superoxide-dependent tumor cell migration, invasion, clonogenicity, and metastasis. Consequently, specific scavenging of mitochondrial superoxide with mitoTEMPO blocked tumor cell migration and prevented spontaneous tumor metastasis in murine and human tumor models.
    Cancer Research 07/2014; 74(19 Supplement). DOI:10.1016/j.celrep.2014.06.043 · 9.28 Impact Factor
  • Source
    • "A rationale for using antioxidants in HIF-1/2α-driven tumors was recently provided by Gao et al., who examined the antitumorigenic effect of the antioxidant NAC (Gao, et al. 2007). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Warburg's metabolic hypothesis is based on the assumption that a cancer cell's respiration must be under attack, leading to its damage, in order to obtain increased glycolysis. Although this may not apply to all cancers, there is some evidence proving that primarily abnormally functioning mitochondrial complexes are indeed related to cancer development. Thus, mutations in complex II (succinate dehydrogenase (SDH)) lead to the formation of pheochromocytoma/paraganglioma. Mutations in one of the SDH genes (SDHx mutations) lead to succinate accumulation associated with very low fumarate levels, increased glutaminolysis, the generation of reactive oxygen species (ROS), and pseudohypoxia. This results in significant changes in signaling pathways (many of them dependent on the stabilization of hypoxia-inducible factor (HIF)) including oxidative phosphorylation, glycolysis, specific expression profiles, as well as genomic instability and increased mutability resulting in tumor development. Although there is currently no very effective therapy for SDHx-related metastatic pheochromocytomas/paragangliomas, targeting their fundamental metabolic abnormalities may provide a unique opportunity for the development of novel and more effective forms of therapy for these tumors.
    Endocrine Related Cancer 02/2014; DOI:10.1530/ERC-13-0398 · 4.91 Impact Factor
  • Source
    • "We also recently reported that aggressive melanoma cells respond to hypoxia engaging a motogen escaping strategy, based on redox stabilization of HIF-1 and activation of the Met protooncogene, allowing a proteolytic motility enhancing metastatic dissemination to lungs [69]. In keeping with the key role exerted by ROS in sensing the effects of hypoxia, Gao et al. reported that the antitumorigenic effect of antioxidants as N-acetyl cysteine and vitamin C in murine models of Myc-mediated tumorigenesis is indeed HIF-1- dependent [70]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Conversely to normal cells, where deregulated oxidative stress drives the activation of death pathways, malignant cells exploit oxidative milieu for its advantage. Cancer cells are located in a very complex microenvironment together with stromal components that participate to enhance oxidative stress to promote tumor progression. Indeed, convincing experimental and clinical evidence underline the key role of oxidative stress in several tumor aspects thus affecting several characteristics of cancer cells. Oxidants influence the DNA mutational potential, intracellular signaling pathways controlling cell proliferation and survival and cell motility and invasiveness as well as control the reactivity of stromal components that is fundamental for cancer development and dissemination, inflammation, tissue repair, and de novo angiogenesis. This paper is focused on the role of oxidant species in the acquisition of two mandatory features for aggressive neoplastic cells, recently defined by Hanahan and Weinberg as new "hallmarks of cancer": tumor microenvironment and metabolic reprogramming of cancer cells.
    International Journal of Cell Biology 05/2012; 2012:762825. DOI:10.1155/2012/762825
Show more